Healthcare -
Biotechnology - NASDAQ - US
$ 10.14
-2.12 %
$ 764 M
Market Cap
-3.34
P/E
REPL - TOTAL RECEIVABLES
Total Receivables REPL - Replimune Group, Inc.
4.92 M
LAST VALUE
26.93%
2 YEAR CAGR
14.75%
5 YEAR CAGR
0.00%
10 YEAR CAGR